158 related articles for article (PubMed ID: 18056193)
21. Gender dictates the nuclear receptor-mediated regulation of CYP3A44.
Anakk S; Huang W; Staudinger JL; Tan K; Cole TJ; Moore DD; Strobel HW
Drug Metab Dispos; 2007 Jan; 35(1):36-42. PubMed ID: 17020958
[TBL] [Abstract][Full Text] [Related]
22. Genetic polymorphisms of CYP1A2, CYP3A4, CYP3A5, pregnane/steroid X receptor and constitutive androstane receptor in 207 healthy Spanish volunteers.
Oliver P; Lubomirov R; Carcas A
Clin Chem Lab Med; 2010 May; 48(5):635-9. PubMed ID: 20218903
[TBL] [Abstract][Full Text] [Related]
23. Expression of constitutive androstane receptor, hepatic nuclear factor 4 alpha, and P450 oxidoreductase genes determines interindividual variability in basal expression and activity of a broad scope of xenobiotic metabolism genes in the human liver.
Wortham M; Czerwinski M; He L; Parkinson A; Wan YJ
Drug Metab Dispos; 2007 Sep; 35(9):1700-10. PubMed ID: 17576804
[TBL] [Abstract][Full Text] [Related]
24. Kupffer cells and reactive oxygen species partially mediate lipopolysaccharide-induced downregulation of nuclear receptor pregnane x receptor and its target gene CYP3a in mouse liver.
Xu DX; Wei W; Sun MF; Wu CY; Wang JP; Wei LZ; Zhou CF
Free Radic Biol Med; 2004 Jul; 37(1):10-22. PubMed ID: 15183191
[TBL] [Abstract][Full Text] [Related]
25. Combined effects of hepatocyte nuclear factor 4α and constitutive androstane receptor on stable warfarin doses.
Moon JY; Lee KE; Chang BC; Jeong E; Jeong H; Gwak HS
Pharmacogenet Genomics; 2015 Jan; 25(1):38-40. PubMed ID: 25356900
[TBL] [Abstract][Full Text] [Related]
26. Identification of polymorphisms in the 3'-untranslated region of the human pregnane X receptor (PXR) gene associated with variability in cytochrome P450 3A (CYP3A) metabolism.
Oleson L; von Moltke LL; Greenblatt DJ; Court MH
Xenobiotica; 2010 Feb; 40(2):146-62. PubMed ID: 20082578
[TBL] [Abstract][Full Text] [Related]
27. Rat pregnane X receptor: molecular cloning, tissue distribution, and xenobiotic regulation.
Zhang H; LeCulyse E; Liu L; Hu M; Matoney L; Zhu W; Yan B
Arch Biochem Biophys; 1999 Aug; 368(1):14-22. PubMed ID: 10415106
[TBL] [Abstract][Full Text] [Related]
28. Expression and induction by rifampicin of CAR- and PXR-regulated CYP2B and CYP3A in liver, kidney and airways of pig.
Nannelli A; Chirulli V; Longo V; Gervasi PG
Toxicology; 2008 Oct; 252(1-3):105-12. PubMed ID: 18786598
[TBL] [Abstract][Full Text] [Related]
29. Hepatic OATP1B transporters and nuclear receptors PXR and CAR: interplay, regulation of drug disposition genes, and single nucleotide polymorphisms.
Meyer zu Schwabedissen HE; Kim RB
Mol Pharm; 2009; 6(6):1644-61. PubMed ID: 19558188
[TBL] [Abstract][Full Text] [Related]
30. From mouse to man: predictions of human pharmacokinetics of orally administered docetaxel from preclinical studies.
Koolen SL; van Waterschoot RA; van Tellingen O; Schinkel AH; Beijnen JH; Schellens JH; Huitema AD
J Clin Pharmacol; 2012 Mar; 52(3):370-80. PubMed ID: 21505085
[TBL] [Abstract][Full Text] [Related]
31. A Transcriptional Regulatory Network Containing Nuclear Receptors and Long Noncoding RNAs Controls Basal and Drug-Induced Expression of Cytochrome P450s in HepaRG Cells.
Chen L; Bao Y; Piekos SC; Zhu K; Zhang L; Zhong XB
Mol Pharmacol; 2018 Jul; 94(1):749-759. PubMed ID: 29691280
[TBL] [Abstract][Full Text] [Related]
32. Nuclear receptor coactivator 6 mediates the synergistic activation of human cytochrome P-450 2C9 by the constitutive androstane receptor and hepatic nuclear factor-4alpha.
Surapureddi S; Rana R; Reddy JK; Goldstein JA
Mol Pharmacol; 2008 Sep; 74(3):913-23. PubMed ID: 18552123
[TBL] [Abstract][Full Text] [Related]
33. A phase I study of docetaxel with ketoconazole modulation in patients with advanced cancers.
Yong WP; Wang LZ; Tham LS; Wong CI; Lee SC; Soo R; Sukri N; Lee HS; Goh BC
Cancer Chemother Pharmacol; 2008 Jul; 62(2):243-51. PubMed ID: 17909805
[TBL] [Abstract][Full Text] [Related]
34. Expression of CYP3A23/1, CYP3A2, PXR, CAR and HNF4alpha in large-for-gestational-age neonatal rats.
Ni S; Wang X; Wang J; Zeng S; Zhao Z
Pharmazie; 2009 Apr; 64(4):252-7. PubMed ID: 19435144
[TBL] [Abstract][Full Text] [Related]
35. Novel single nucleotide polymorphisms in the promoter and intron 1 of human pregnane X receptor/NR1I2 and their association with CYP3A4 expression.
Lamba J; Lamba V; Strom S; Venkataramanan R; Schuetz E
Drug Metab Dispos; 2008 Jan; 36(1):169-81. PubMed ID: 17925385
[TBL] [Abstract][Full Text] [Related]
36. Dexamethasone as a probe for docetaxel clearance.
Puisset F; Chatelut E; Dalenc F; Busi F; Cresteil T; Azéma J; Poublanc M; Hennebelle I; Lafont T; Chevreau C; Roché H
Cancer Chemother Pharmacol; 2004 Sep; 54(3):265-72. PubMed ID: 15133628
[TBL] [Abstract][Full Text] [Related]
37. Activation of Pregnane X Receptor-Cytochrome P450s Axis: A Possible Reason for the Enhanced Accelerated Blood Clearance Phenomenon of PEGylated Liposomes In Vivo.
Wang F; Wang H; Wu Y; Wang L; Zhang L; Ye X; Peng D; Chen W
Drug Metab Dispos; 2019 Aug; 47(8):785-793. PubMed ID: 31118196
[TBL] [Abstract][Full Text] [Related]
38. NCT01110291: induction of CYP3A activity and lowered exposure to docetaxel in patients with primary breast cancer.
Hilli J; Sailas L; Jyrkkiö S; Pyrhönen S; Laine K
Cancer Chemother Pharmacol; 2011 Jun; 67(6):1353-62. PubMed ID: 20798939
[TBL] [Abstract][Full Text] [Related]
39. PXR pharmacogenetics: association of haplotypes with hepatic CYP3A4 and ABCB1 messenger RNA expression and doxorubicin clearance in Asian breast cancer patients.
Sandanaraj E; Lal S; Selvarajan V; Ooi LL; Wong ZW; Wong NS; Ang PC; Lee EJ; Chowbay B
Clin Cancer Res; 2008 Nov; 14(21):7116-26. PubMed ID: 18981011
[TBL] [Abstract][Full Text] [Related]
40. Nuclear receptors and drug metabolism for the personalization of cancer therapy.
Cecchin E; De Mattia E; Toffoli G
Expert Opin Drug Metab Toxicol; 2016; 12(3):291-306. PubMed ID: 26789519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
